HLB Pharmaceutical Co Ltd 047920
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 21,600.00
- Day Range
- KRW 15,150.00–16,800.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 15,570.00 / KRW 15,580.00
- Market Cap
- —
- Volume/Avg
- 9.8 Mil / 1.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.41
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 230
- Website
- http://www.hlbpharma.co.kr
Comparables
Valuation
|
Metric
|
047920
|
016580
|
293480
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 7.41 | 10.17 |
Price/Book Value | 4.05 | 0.61 | 0.83 |
Price/Sales | 3.41 | 0.93 | 1.02 |
Price/Cash Flow | — | 5.32 | 7.51 |
Price/Earnings
047920
016580
293480
Financial Strength
|
Metric
|
047920
|
016580
|
293480
|
|---|---|---|---|
Quick Ratio | 1.03 | 3.11 | — |
Current Ratio | 1.46 | 4.35 | 2.27 |
Interest Coverage | −0.64 | 1,519.46 | — |
Quick Ratio
047920
016580
293480
Profitability
|
Metric
|
047920
|
016580
|
293480
|
|---|---|---|---|
Return on Assets (Normalized) | −14.16% | 8.25% | 6.72% |
Return on Equity (Normalized) | −22.98% | 9.30% | 8.59% |
Return on Invested Capital (Normalized) | −10.62% | 8.37% | 7.47% |
Return on Assets
047920
016580
293480
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Gbkxlmddzz | Jfgv | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Mqxtvntnm | Mpgqvh | $79.0 Bil | |
HLN
| Haleon PLC ADR | Dqkswwfp | Fhjcn | $38.5 Bil | |
VTRS
| Viatris Inc | Szhdzftlb | Fmvpt | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Bddzzqpw | Bmkhd | $11.7 Bil | |
CTLT
| Catalent Inc | Ycgkqlzt | Gftgwp | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Ykphkrnk | Wxcjf | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Qrtfgbyq | Xqx | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wsznjtvv | Czvwrr | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Rsklsrzj | Fthb | $3.1 Bil |